Robert Eckert - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Independent Director

Mr. Robert A. Eckert is Lead Independent Director of Amgen Inc. Robert A. Eckert was an Operating Partner at Friedman Fleischer Lowe, a private equity firm, since September 2014. Mr. Eckert was the Chief Executive Officer of Mattel, Inc., a toy design, manufacture and marketing company, having held this position from 2000 through December 2011, and its Chairman of the Board from 2000 through 2012. He was President and Chief Executive Officer of Kraft Foods Inc., a consumer packaged food and beverage company, from 1997 to 2000, Group Vice President from 1995 to 1997, President of the Oscar Mayer Foods Division from 1993 to 1995 and held various other senior executive and other positions from 1977 to 1992. Mr. Eckert was a director of McDonalds Corporationrationration, a company which franchises and operates McDonalds restaurants in the global restaurant industry, since 2003, serving as the Chair of the Compensation Committee and a member of the Executive and Governance Committees. Mr. Eckert was a director of Smart Final Stores, Inc., a warehouse store, from May 2013 until July 2014 prior to it becoming a publiclytraded company. Mr. Eckert also has served as a director of Levi Strauss Co., a privatelyheld jeans and casual wear manufacturer, since 2010. He was appointed director of Eyemart Express Holdings LLC, a privatelyheld eyewear retailer and portfolio company of Friedman Fleischer Lowe, in 2015. Mr. Eckert is on the Global Advisory Board of the Kellogg School of Management at Northwestern University and serves on the Eller College National Board of Advisors at the University of Arizona
Age: 61  Director Since 2016      
805 447-1010  www.amgen.com
Eckert received an undergraduate degree from the University of Arizona and a master?s degree in business administration from the Kellogg School of Management at Northwestern University.

Robert Eckert Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Patrick OSullivanAllergan plc
2013
James FarrellAbbott Laboratories
2006
William OsbornAbbott Laboratories
2013
Nesli BasgozAllergan plc
2014
Daniel StarksAbbott Laboratories
2017
Nancy McKinstryAbbott Laboratories
2011
Edward LiddyAbbott Laboratories
2010
Samuel ScottAbbott Laboratories
2007
Joseph BoccuziAllergan plc
2017
James BloemAllergan plc
2013
Shane CookeEndo International plc
2014
David AltshulerVertex Pharmaceuticals Incorpor
2015
John StrattonAbbott Laboratories
2017
Robert AlpernAbbott Laboratories
2008
Bruce SachsVertex Pharmaceuticals Incorpor
2017
Deborah NeffBio Rad Laboratories Inc
2011
Alice SchwartzBio Rad Laboratories Inc
1967
Nancy HutsonEndo International plc
2009
William SpenglerEndo International plc
2008
Adriane BrownAllergan plc
2017
David GreenwayVertex Pharmaceuticals Incorpor
2017

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Price Ceiling Movement Now
   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
Hide  View All  NextLaunch Price Ceiling Movement
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators